CN101108226A - Medicament treating rheumatism, rheumatoid, woman's wind, osteoproliferation and slipped disc illness - Google Patents
Medicament treating rheumatism, rheumatoid, woman's wind, osteoproliferation and slipped disc illness Download PDFInfo
- Publication number
- CN101108226A CN101108226A CNA2006100170493A CN200610017049A CN101108226A CN 101108226 A CN101108226 A CN 101108226A CN A2006100170493 A CNA2006100170493 A CN A2006100170493A CN 200610017049 A CN200610017049 A CN 200610017049A CN 101108226 A CN101108226 A CN 101108226A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rheumatism
- rheumatoid
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a treatment for rheumatism, rheumatoid, postpartum rheumatism, hyperosteogeny and lumbar disc herniation. The commodity name of the herbal medicine is 'Wind-cold-dampness Dispersed Powder' or 'Wind-cold-dampness Dispersed Capsule', and is a normally used TCM made of ephedra, achyranthis bidentatae, homalonemae rhizome, Chinese wolfberry fruit, parsnip, angelica, notopterygium, encommiae ulmoide carbon, cassia twig, mastic-frank incense, myrrha, pawpaw, Schizophragma integrifolium Oliv, anoelicae sinensis, liquorice, lovage and radix paeoniaalba. The madcine is quite efficient for rheumatism, rheumatoid, postpartum rheumatism, hyperosteogeny and lumbar disc herniation. Compared with other similar drugs, the invention can not only treat the symptoms but also the root cause. The clinical observation has proved the invention can treat rheumatism, rheumatoid, postpartum rheumatism, hyperosteogeny and lumbar disc herniation with exact effect and low cost. Compared with chemical drugs, the invention does not boast high efficacy, but also has less negative effects. As long as the patients use the medicine as required, the relapsed and invalidity cases will be significantly reduced.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine, belong to the field of Chinese medicines, a kind of specifically medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc.
Background technology
Rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc belong to the Chinese medicine wind-cold damp pathogen and hinder, be one of commonly encountered diseases and frequently-occurring disease clinically, rheumatism, the rheumatoid pilosity is crowd more than 15 years old, puerperal exposure to wind is many morbidity in more than 20 year old, hyperosteogeny mostly occurs at middle-aged and elderly people more than more than 40 year old, and the trend of oriented younger development, its pathogeny is to replenish deficiency or lose relevant too much because of present human calcium ion, prolapse of lumbar intervertebral disc mostly occurs the patient more than 20 years old, the trend of increasing is arranged now, its factor may be in the rare pass of mankind's activity amount, but the waist ligament why the slacken reason is not still understood, remain further research.
More than all diseases once the morbidity, all can influence and work and take care of oneself, lifelong deformity can appear in the delay treatment person, more to the medicine of above all sick treatments at present, doctor trained in Western medicine is treated with hormone and analgesic, and hormone is bigger to the human body destructiveness, and forms dependence, some drug price costliness on the market does not reach the purpose for the treatment of both the principal and secondary aspects of a disease.Therefore the present invention is the medicine that a kind for the treatment of both the principal and secondary aspects of a disease of research is treated above-mentioned all diseases, and this also is pressing for of current medical circle.
Summary of the invention
The objective of the invention is to overcome above-mentioned the deficiencies in the prior art, a kind of instant effect is provided, evident in efficacy, toxic and side effects is little, the medicine of treatment rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and the disease of proplapse of lumbar intervertebral disc for the treatment of both the principal and the secondary aspects of a disease at the same time.
Rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc, more than all sick traditional Chinese medical science " element is asked, numbness opinion " point out " wind, cold, wet three gas are assorted extremely, close and are numbness, its migratory BI-syndrome caused mainly by pathogenic wind; BI-syndrome caused mainly by pathogenic cold being called painful BI; the dampness victor be all numbness " wind, tremble with fear, damp lingers in muscles and bones, then pain unbearably, disease is deeply with the passing of time, it is puckery that battalion defends trip, skin is not sought, and then apathetic, pathogenic factor is deep." numbness opinion " also think numbness to result from the dietetic life environment relevant, can invade the five internal organs six abdomens, modern medicine thinks, rheumatism, rheumatoid, is to cause allergy after being infected by group B streptococcus, it is consistent can extensively invading organ such as heart.The prolapse of lumbar intervertebral disc and the hyperosteogeny traditional Chinese medical science say it is to cross victory by dampness to be hindered in addition, and the numbness of " numbness opinion " indication is that disease deeply with the passing of time by wind, cold, wet all gas cut human bodies, it is puckery that battalion defends trip, and pathogenic factor is deep, eliminating to treat the excess syndrome, must drive it, can answer also, so in treatment, with wind dispelling cold expelling, wet eliminating impediment, collateral dredging relieves the pain, the method of strengthening kidney and tonifying bone, thus select for use Herba Ephedrae, Cortex schizophragmatis integrifolii radicis, Fructus Chaenomelis, Radix Saposhnikoviae, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Rhizoma Homalomenae that the wind dispelling cold expelling is all arranged, the effect of warm eliminating impediment.In addition, Ramulus Cinnamomi, Semen Strychni, Olibanum, Myrrha can loose and separate detumescence, removing obstruction in the collateral to relieve pain, river Niu Xi, charred Cortex Eucommiae, fructus lycii, and all the energy invigorating the liver and kidney reaches the purpose of reinforcing waist and strengthening bone.Moreover Radix Angelicae Sinensis, the Radix Paeoniae Alba, Radix Glycyrrhizae 5 usefulness play anxious pain relieving, the mediation property of medicine, double cold coagulation and the disharmony of nutrient QI with defensive QI etc. controlled.
Said medicine is share, can effectively reach, wind dispelling cold expelling, wet eliminating impediment, activating collaterals to relieve pain, strengthening kidney and tonifying bone, institute so that all clinically condition of illness alleviate or disappear.Effective percentage is very high in treatment.
The object of the present invention is achieved like this, the medicament that the present invention is made by the following weight proportion raw material:
Herba Ephedrae 30-65 part river cattle sunset 5-15 part Rhizoma Homalomenae 5-10 part fructus lycii 5-10 part
Radix Saposhnikoviae 5-10 part Rhizoma Et Radix Notopterygii 5-10 part Semen Strychni 5-12 part charred Cortex Eucommiae 5-15 part
Ramulus Cinnamomi 5-15 part Olibanum 5-15 part Myrrha 5-15 part Fructus Chaenomelis 20-25 part
Cortex schizophragmatis integrifolii radicis 20-25 part Radix Angelicae Sinensis 5-15 part Radix Glycyrrhizae 5-15 part Radix Angelicae Pubescentis 5-10 part
Radix Paeoniae Alba 5-10 part.
The preferable amount proportioning of drug regimen of the present invention is:
Herba Ephedrae 30-65 part river cattle sunset 7-10 part Rhizoma Homalomenae 7-10 part fructus lycii 8-15 part
Radix Saposhnikoviae 7-10 part Rhizoma Et Radix Notopterygii 7-10 part Semen Strychni 8-12 part charred Cortex Eucommiae 8-15 part
Ramulus Cinnamomi 8-15 part Olibanum 8-15 part Myrrha 8-15 part Fructus Chaenomelis 20-25 part
Cortex schizophragmatis integrifolii radicis 20-25 part Radix Angelicae Sinensis 8-10 part Radix Glycyrrhizae 8-10 part Radix Angelicae Pubescentis 7-10 part
Radix Paeoniae Alba 7-10 part.
The optimum amount proportioning of pharmaceutical composition of the present invention is:
10 parts of 10 parts of Radix Saposhnikoviaes of Herba Ephedrae 10 parts of fructus lyciis of 65 parts of river cattle sunset, 10 parts of Rhizoma Homalomenaes
15 parts of 10 parts of Olibanums of 15 parts of Ramulus Cinnamomi of 12 parts of charred Cortex Eucommiaes of 10 parts of Semen Strychnis of Rhizoma Et Radix Notopterygii
15 parts in 15 portions of Radix Glycyrrhizaes of 25 parts of Radix Angelicae Sinensis of 25 parts of Cortex schizophragmatis integrifolii radicis of 15 portions of Fructus Chaenomeliss of Myrrha
10 parts of 10 portions of Radix Paeoniae Albas of Radix Angelicae Pubescentis.
Pharmaceutical composition of the present invention can be prepared from any suitable according to the process of Chinese medicine preparation of routine
Close the pharmaceutical preparation of using in clinically, as tablet, powder, capsule, pill etc.
Preferred dosage form of the present invention is powder and capsule, and its preparation method is:
(1) earlier oven dry is processed in the Semen Strychni stir-fry and pulverized 120 mesh sieves.
(2) 120 mesh sieves were pulverized in river Niu Xi, Rhizoma Homalomenae, fructus lycii, Radix Saposhnikoviae, charred Cortex Eucommiae, Ramulus Cinnamomi, Olibanum, Myrrha, Radix Angelicae Sinensis, Radix Glycyrrhizae oven dry.
(3) the part composition of medicine that will not pulverize again decocts.
(4) medicine of pulverizing and the medicinal liquid of decoction are stirred, dry, pulverize.
(5) reuse 120 mesh sieves sieve and stir, subpackage or incapsulate, and every bag or grain weight reach 0.5 gram, are equipped with clothes.
Drug use method of the present invention is:
1, treatment: the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and prolapse of lumbar intervertebral disc, from making a definite diagnosis day, taking " anemofrigid-damp arthralgia is logical to dissipate or capsule " every day takes 3 every day, at every turn at 2.0 grams, begin after serveing on 10 to take effect, then begin to obey the course of treatment, treatment rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny 3-4 can cure a course of treatment, the prolapse of lumbar intervertebral disc patient must not obey the course of treatment.
2, rehabilitation: after the patient of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and prolapse of lumbar intervertebral disc takes medicine, transference cure or obviously alleviate, the person that do not return to one's perfect health this moment please hold on and take medicine.
Rheumatism, rheumatoid, puerperal exposure to wind patient transference cure, chemical examination resists " 0 " and rheumatoid factor negative every other month, continuous 3 complete healing.Prolapse of lumbar intervertebral disc patient clinical symptoms and the equal feminine gender of sign after taking medicine are carried out comings and goings is not all had overslaugh, and the CT report is normal to be rehabilitation.
Medicine of the present invention is compared with similar Chinese medicine, has the following advantages:
(1), when clinical drug of the present invention is used for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and prolapse of lumbar intervertebral disc, can reaches really and drive district's cold expelling, the effect of wet eliminating impediment, removing obstruction in the collateral to relieve pain, strengthening kidney and tonifying bone.Clinical proof not only symptom is eliminated soon, can also soften bony spur, and reduce relapse rate and disability rate that above-mentioned all kinds of disease causes significantly.
(2), medicine of the present invention compares with similar Chinese medicine, this medicine can not only take stopgap measures and can also effect a permanent cure, and reaches the purpose for the treatment of both the principal and secondary aspects of a disease.This medicine is taking convenience not only, and instant effect.
(3), compare, not only curative effect is big, and except that not containing the hormone, this medicine does not have the property of accumulating, no drug resistance and addiction, advantage such as toxic and side effects is few with chemicals.
For showing the therapeutic effect of the present invention to rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and prolapse of lumbar intervertebral disc, 620 routine rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and prolapse of lumbar intervertebral disc patient are divided into two groups contrast treatment, two groups of ages, sex and diseases all adopt random sampling pattern, wherein 620 examples are organized in treatment, and matched group 100 routine clinical development standards are according to the above-mentioned all sick efficacy assessment standard evaluation of passing through about rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and prolapse of lumbar intervertebral disc research association for Chinese Medical Association's whole nation traditional Chinese medical science (concrete evaluation criteria is simple).
The treatment group adopts logical dissipation of anemofrigid-damp arthralgia and capsule, and matched group adopts hormone and active star, takes through the clinical statement oral methods, and clinical practice shows effective percentage apparently higher than matched group, and P value＜0.05 proves notable difference (seeing table 1 for details).
Table 1 smelting treatment group and the comparison of photograph group curative effect (X ± S)
| The example number | Produce effects | Effectively | Invalid | Total effective rate | ||
| N | N ％ | N ％ | N ％ | N ％ | The D value | |
| The treatment group | 620 | 486 78.2 | 125 20.1 | 7 1.1 | 611 98.3 | ＜0.05 |
| Matched group | 100 | 32 32 | 25 25 | 23 23 | 57 57 |
In 620 example treatment cases, wherein the man suffers from 322 examples, and the woman suffers from 398 examples, and men and women's ratio is nonsensical.
In 620 example treatment cases, the age distribution situation is maximum 82 years old, minimal ages 13 years old, clinical trial certificate, anemofrigid-damp arthralgia is logical to dissipate and capsule, all effective to each age group patient, we carry out tracing observation to the convalescent of treatment group and matched group simultaneously, observe its relapse rate, the result shows, treatment group and matched group are widely different, with 1 year be the contrast time, matched group is after treatment, the patient of recurrence is higher than the treatment group, and there is notable difference (seeing table 2 for details) P value＜0.05
After being treated, table 2, treatment group and matched group recur contrast table again
| The example number | Produce effects | Effectively | Recurrence | Total relapse rate | ||
| N | N | N | N | N ％ | The P value | |
| The treatment group | 611 | 486 | 125 | 7 | 5 0.8 | ＜0.05 |
| Matched group | 57 | 32 | 25 | 9 | 9 16 |
The specific embodiment
Earlier Semen Strychni is fried and processed, again 10 parts of the river cattle sunset in the composition of medicine, 10 parts of Rhizoma Homalomenaes, 10 parts of fructus lyciis, Radix Saposhnikoviae 10 minutes, 15 parts of charred Cortex Eucommiaes, 10 parts of Ramulus Cinnamomi, 15 parts of Olibanums, 15 parts of Myrrhas, 15 parts of Radix Angelicae Sinensis, 10 parts of the Radix Paeoniae Albas, Radix Glycyrrhizae are dried pulverizing for 15 parts, with 120 mesh sieves medicine being sieved then stirs, stand-by.Other remaining set composite medicine adds water and soaked 1 hour for 1500 milliliters, and the back decocted 1 hour, after taking out medicinal liquid, add 1000 milliliters in water again, decoct again about 30 minutes, carrying out twice same water of usefulness and time continuously decocts, and decocts medicinal liquids with three times and leaves standstill sedimentation and filtration, reheat is concentrated into 500 milliliters, the composition of medicine of stand-by pulverizing is stirred, and oven dry is pulverized once more, and then get 120 mesh sieves, all composition of medicine are sieved to stir.The medicine subpackage of pulverizing or incapsulate, every bag or grain weigh 0.5 gram, every day three times, each 2.0 grams.
Claims (5)
1. medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and prolapse of lumbar intervertebral disc, it is characterized in that: it is the medicament of being made by the following weight proportion raw material:
Herba Ephedrae 30-65 part river cattle sunset 5-15 part Rhizoma Homalomenae 5-10 part fructus lycii 5-10 part
Radix Saposhnikoviae 5-10 part Rhizoma Et Radix Notopterygii 5-10 part Semen Strychni 5-12 part charred Cortex Eucommiae 5-15 part
Ramulus Cinnamomi 5-10 part Olibanum 5-15 part Myrrha 5-15 part Fructus Chaenomelis 20-25 part
Cortex schizophragmatis integrifolii radicis 20-25 part Radix Angelicae Sinensis 5-15 part Radix Glycyrrhizae 5-15 part Radix Angelicae Pubescentis 5-10 part
Radix Paeoniae Alba 5-10 part.
2. require 1 described a kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and prolapse of lumbar intervertebral disc according to letter of authorization, it is characterized in that: wherein each proportion of raw materials is:
Herba Ephedrae 30-65 part river cattle sunset 7-10 part Rhizoma Homalomenae 7-10 part fructus lycii 8-10 part
Radix Saposhnikoviae 7-10 part Rhizoma Et Radix Notopterygii 7-10 part Semen Strychni 8-12 part charred Cortex Eucommiae 8-15 part
Ramulus Cinnamomi 8-15 part Olibanum 8-15 part Myrrha 8-15 part Fructus Chaenomelis 20-25 part
Cortex schizophragmatis integrifolii radicis 20-25 part Radix Angelicae Sinensis 8-10 part Radix Glycyrrhizae 8-10 part Radix Angelicae Pubescentis 7-10 part
Radix Paeoniae Alba 7-10 part.
3. require 1 described a kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and prolapse of lumbar intervertebral disc according to letter of authorization, it is characterized in that: wherein each proportion of raw materials is:
10 parts of 10 parts of Radix Saposhnikoviaes of Herba Ephedrae 10 parts of fructus lyciis of 65 parts of river cattle sunset, 10 parts of Rhizoma Homalomenaes
15 parts of 10 parts of Olibanums of 15 parts of Ramulus Cinnamomi of 12 parts of charred Cortex Eucommiaes of 10 parts of Semen Strychnis of Rhizoma Et Radix Notopterygii
15 parts in 15 portions of Radix Glycyrrhizaes of 25 parts of Radix Angelicae Sinensis of 25 parts of Cortex schizophragmatis integrifolii radicis of 15 portions of Fructus Chaenomeliss of Myrrha
10 parts of 10 portions of Radix Paeoniae Albas of Radix Angelicae Pubescentis.
4. require 1 or 2 or 3 described a kind of medicines for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and prolapse of lumbar intervertebral disc according to letter of authorization, it is characterized in that: the dosage form of this medicine is powder, capsule preparations.
5. require 4 described a kind of preparation methoies for the treatment of the medicine of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and prolapse of lumbar intervertebral disc according to letter of authorization, it is characterized in that: the preparation method of described powder and capsule preparations is:
(1) earlier oven dry is processed in the Semen Strychni stir-fry and pulverized 120 mesh sieves;
(2) 120 mesh sieves were pulverized in river Niu Xi, Rhizoma Homalomenae, fructus lycii, Radix Saposhnikoviae, charred Cortex Eucommiae, Ramulus Cinnamomi, Olibanum, Myrrha, Radix Angelicae Sinensis, Radix Glycyrrhizae oven dry,
(3) the part composition of medicine that will not pulverize again decocts;
(4) medicine of pulverizing and the medicinal liquid of decoction are stirred, dry, pulverize;
(5) reuse 120 mesh sieves sieve and stir, subpackage or incapsulate, and every bag or grain weight reach 0.5 gram, are equipped with clothes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100170493A CN100563690C (en) | 2006-07-20 | 2006-07-20 | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100170493A CN100563690C (en) | 2006-07-20 | 2006-07-20 | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101108226A true CN101108226A (en) | 2008-01-23 |
| CN100563690C CN100563690C (en) | 2009-12-02 |
Family
ID=39040614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100170493A Expired - Fee Related CN100563690C (en) | 2006-07-20 | 2006-07-20 | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100563690C (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101816729A (en) * | 2010-03-03 | 2010-09-01 | 鲍旭刚 | Medicament for treating arthritis and preparation method thereof |
| CN102526261A (en) * | 2012-02-21 | 2012-07-04 | 简福川 | Chinese medicine for treating lumbar vertebra osteoproliferation |
| CN102579625A (en) * | 2012-03-07 | 2012-07-18 | 南京同仁堂药业有限责任公司 | Preparation method of Chinese medicinal dropping pills for treating rheumatoid arthritis |
| CN102614388A (en) * | 2012-04-25 | 2012-08-01 | 董宜忠 | Chinese medicinal wine for treating rheumatoid arthritis and preparation method thereof |
| CN102935154A (en) * | 2012-12-06 | 2013-02-20 | 冷凤珍 | Traditional Chinese medicinal preparation for treating lumbar disc herniation |
| CN103623249A (en) * | 2013-12-05 | 2014-03-12 | 韩友群 | Traditional Chinese medicine oral preparation for treating orthopedic disorders and preparation method thereof |
| CN104069271A (en) * | 2014-07-22 | 2014-10-01 | 曹共和 | Hyperosteogeny medicine |
| CN104208290A (en) * | 2014-08-22 | 2014-12-17 | 赵红丽 | Composition for treating postpartum rheumatism by mud moxibustion |
| CN104383166A (en) * | 2014-10-27 | 2015-03-04 | 杨晓军 | Medicine for treating rheumatic lumbocrural pains and preparation method thereof |
| CN104587105A (en) * | 2015-01-30 | 2015-05-06 | 刘雨秋 | Traditional Chinese medicine for treating rheumatoid arthritis and rheumatoid diseases |
| CN109419954A (en) * | 2017-09-05 | 2019-03-05 | 辽宁泓新科技成果转化服务有限公司 | A kind of ointment and its device for treating prolapse of lumbar intervertebral disc |
| CN111467396A (en) * | 2020-04-30 | 2020-07-31 | 邵俊信 | Oral capsule for treating ostealgia |
| CN112168908A (en) * | 2019-07-05 | 2021-01-05 | 黄胜昔 | Traditional Chinese medicine for treating wind-cold-dampness arthralgia and tendon and vessel discomfort and preparation method thereof |
| CN113082081A (en) * | 2020-01-08 | 2021-07-09 | 韩长序 | External medicinal liquor for lumbar intervertebral disc |
-
2006
- 2006-07-20 CN CNB2006100170493A patent/CN100563690C/en not_active Expired - Fee Related
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101816729A (en) * | 2010-03-03 | 2010-09-01 | 鲍旭刚 | Medicament for treating arthritis and preparation method thereof |
| CN102526261A (en) * | 2012-02-21 | 2012-07-04 | 简福川 | Chinese medicine for treating lumbar vertebra osteoproliferation |
| CN102579625A (en) * | 2012-03-07 | 2012-07-18 | 南京同仁堂药业有限责任公司 | Preparation method of Chinese medicinal dropping pills for treating rheumatoid arthritis |
| CN102614388A (en) * | 2012-04-25 | 2012-08-01 | 董宜忠 | Chinese medicinal wine for treating rheumatoid arthritis and preparation method thereof |
| CN102935154A (en) * | 2012-12-06 | 2013-02-20 | 冷凤珍 | Traditional Chinese medicinal preparation for treating lumbar disc herniation |
| CN103623249A (en) * | 2013-12-05 | 2014-03-12 | 韩友群 | Traditional Chinese medicine oral preparation for treating orthopedic disorders and preparation method thereof |
| CN104069271A (en) * | 2014-07-22 | 2014-10-01 | 曹共和 | Hyperosteogeny medicine |
| CN104069271B (en) * | 2014-07-22 | 2017-08-15 | 曹共和 | A kind of medicine for treating hyperosteogeny |
| CN104208290A (en) * | 2014-08-22 | 2014-12-17 | 赵红丽 | Composition for treating postpartum rheumatism by mud moxibustion |
| CN104383166A (en) * | 2014-10-27 | 2015-03-04 | 杨晓军 | Medicine for treating rheumatic lumbocrural pains and preparation method thereof |
| CN104587105A (en) * | 2015-01-30 | 2015-05-06 | 刘雨秋 | Traditional Chinese medicine for treating rheumatoid arthritis and rheumatoid diseases |
| CN109419954A (en) * | 2017-09-05 | 2019-03-05 | 辽宁泓新科技成果转化服务有限公司 | A kind of ointment and its device for treating prolapse of lumbar intervertebral disc |
| CN112168908A (en) * | 2019-07-05 | 2021-01-05 | 黄胜昔 | Traditional Chinese medicine for treating wind-cold-dampness arthralgia and tendon and vessel discomfort and preparation method thereof |
| CN113082081A (en) * | 2020-01-08 | 2021-07-09 | 韩长序 | External medicinal liquor for lumbar intervertebral disc |
| CN111467396A (en) * | 2020-04-30 | 2020-07-31 | 邵俊信 | Oral capsule for treating ostealgia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100563690C (en) | 2009-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100563690C (en) | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc | |
| CN101757569A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis and cerebral infarction and preparation method thereof | |
| CN101209337B (en) | Medicinal liquor for treating rheumatism and rheumatoid | |
| CN100376229C (en) | A medicinal wine for treating rheumatic and rheumatoid disease | |
| CN101810835A (en) | Chinese medicinal composition for treating purpura and preparation method thereof | |
| CN100460008C (en) | Chinese medicine composition for treating cancer | |
| CN102091289B (en) | Traditional Chinese medicine preparation for treating acute and chronic soft tissue injuries | |
| CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
| CN101181568B (en) | Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache | |
| CN104398640A (en) | Traditional Chinese medicinal composition for treating prostatitis, and preparation method thereof | |
| CN100518811C (en) | Chinese traditional medicinal preparation for preventing and treating coronary heart disease and angina pectoris | |
| CN106039245A (en) | External traditional Chinese medicine mineral spring mud for treating rheumatoid bone diseases and preparation method thereof | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN103251754A (en) | Traditional Chinese medicine composition for treating bedsore | |
| CN102949507B (en) | Traditional Chinese medicine lotion for treating lumbocrural pain and preparation method thereof | |
| CN105853902A (en) | Plaster for treating lumbar disc herniation and preparation method thereof | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN106389557B (en) | A kind of Chinese medicine composition and its preparation method and application for Chinese medicine moxibustion | |
| CN104857463A (en) | Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis | |
| CN101062340B (en) | Chinese traditional medicine composition for liver revovery | |
| CN105943644B (en) | A kind of Chinese medicine moxibustion composition and its preparation method and application for lumbar muscle strain | |
| CN116942740B (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and application thereof | |
| CN102018765A (en) | Traditional Chinese medicine for treating diabetic acromelic gangrene | |
| CN101912566B (en) | Traditional Chinese medicine for treating palpitation | |
| CN100536895C (en) | Formulaion in traditional chinese medical prescription for treating waist and neck hyperosteogeny |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091202 Termination date: 20130720 |